New visit to Vietnam

By | 2016, News | No Comments

Our general director, Dr. Oscar Ahumada and business development manager, Rosalía Calleja have recently visited Vietnam for meeting some colleagues working on biosensing and nanotechnology projects in Hanoi. Even although this time was a short time visit, they were pleased to visit this wonderful country once more time.

PepMat2016

II PEPMAT 2016

By | 2016, Events, News | No Comments

Barcelona (Spain) – 14th to 16th of March, 2016

We are very pleased to participate in II Peptide Materials for Biomedicine and Nanotechnology (PepMat 2016). This is an international conference dedicated to the most relevant developments in the field of peptide materials and its application to Biomedicine and Nanotechnology. The conference was held from 14 to 16 of March in Barcelona and our General Manager, Dr. Oscar Ahumada, has participated with an oral presentation entitled “Mecwins: developing biomedicine applications using nanomechanical sensors”. After his talk, participants took the opportunity of see our platform SCALA working, which as exhibited during the second day of the congress. We would like to thank to all the friendly people we met during the conference and specially thanks to Prof. Carlos Alemán for his hospitality and invitation to this congress.

This sponsorship can be the beginning of new connections, relationships and developments of final applications in the field of peptides with SCALA.

Further information about the conference by clicking here.

HM CIOCC febrero

TEACHING SESSIONS IN CIOCC

By | 2016, Events, News | No Comments

Madrid (Spain) – 24th of February, 2016

Our General Manager Dr. Oscar Ahumada has been invited to give a talk during the Teaching Sessions organized by Centro Integral Oncológico Clara Campal (CIOCC) that will be held in the auditorium of the Hospital Universitario HM Sanchinarro, Auditorio Reina Sofía the next 24th of February. The topic of this talk is the use of nanotechnology for therapy response under the title “Nanotecnología aplicada al estudio de respuesta a fármacos inmunoterápicos en melanoma y tumores GU”